TELMIN KH 100MG/TAB ΔΙΣΚΙΟ
TELMIN KH 100MG/TAB ΔΙΣΚΙΟ
Authorised
- Mebendazole
Product identification
Medicine name:
TELMIN KH 100MG/TAB ΔΙΣΚΙΟ
Active substance:
- Mebendazole
Target species:
-
Cat
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Mebendazole100.00/milligram(s)300.00milligram(s)
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
-
Cat
-
Not applicableno withdrawal period
-
-
Dog
-
Not applicableno withdrawal period
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AC09
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Package description:
- Available only in Greek
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone)
Marketing authorisation holder:
- Eli Lilly Regional Operations GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Janssen Cilag S.p.A.
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 3189/29-01-1998/K-0117201
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
